Oxipit (part of Sectra group)
About Oxipit (part of Sectra group)
Oxipit, now a part of the Sectra Group, is a leading healthcare AI company specializing in AI-driven medical imaging solutions for radiology. Founded by experts in medicine and data science, the company aims to address the global shortage of radiologists and improve diagnostic efficiency and accuracy. Their flagship product line, the CXR Suite, includes CE-certified AI tools such as ChestLink, the world’s first CE Class IIb-certified autonomous AI imaging application for normal chest X-rays, which can automate up to 40% of healthy chest X-ray reporting.
Beyond chest X-rays, Oxipit has expanded its portfolio to include solutions for chest CT and musculoskeletal imaging. These tools are designed to integrate seamlessly into existing radiology workflows, providing features like AI-assisted detection of findings (e.g., fractures, lung lesions), workflow optimization through urgent case prioritization, and real-time quality assurance to detect missed abnormalities. By automating routine tasks and offering decision support, Oxipit empowers radiologists to focus on complex and high-priority cases, ultimately enhancing diagnostic speed, precision, and patient outcomes.
Focus Areas
Business Intelligence
| Key Investors | CoInvest Capital, EIT Health, European Commission, Health Venture Lab, Lithuanian Business Angel Network, Taiwania Capital, Practica Capital, angel investors |
| Partnerships | Unilabs Group (2025), Blackford, deepc, HealthCare Konnect, CARPL, Vestre Viken Health Trust (2025), German Medical Institute (2026), Leiden University Medical Centre (LUMC) |
| Acquisitions | Acquired by Sectra (April 2026) |
| Technology | Cloud-native (implied by seamless integration into PACS and various deployments), AI operating system (ChestLink as autonomous AI), deep learning |
| FDA Clearances | unknown (company plans to file for US FDA certification in 2023) cleared products (estimated) |
What Physicians Need to Know
For physicians, Oxipit's AI solutions offer a significant advantage by reducing the burden of routine, healthy case reporting, allowing radiologists to focus their expertise on more complex and critical cases. The AI acts as a reliable 'second set of eyes' for quality assurance, helping to catch subtle or easily missed findings and thereby enhancing diagnostic accuracy. The workflow optimization features, including intelligent triage and automated preliminary reports, can lead to faster turnaround times and improved efficiency in radiology departments. Furthermore, the clinically validated nature of their autonomous AI, particularly ChestLink, provides a high level of confidence in automated diagnoses for normal cases. The integration into existing PACS/RIS systems ensures minimal disruption to current workflows, making adoption smoother.
Oxipit's AI solutions are designed for seamless integration with existing PACS (Picture Archiving and Communication Systems) and RIS (Radiology Information Systems) infrastructure. They also collaborate with leading healthcare technology organizations such as Sectra (their parent company), DeepC, Blackford, HCK, and CARPL to ensure broad compatibility and deployment across various healthcare settings.
What the Web Says
Oxipit, now part of Sectra Group, is a leader in AI-driven medical imaging, specializing in solutions for radiology. Their flagship product, ChestLink, is the world's first CE Class IIb-certified autonomous AI imaging application capable of identifying normal chest X-ray studies with high sensitivity, aiming to reduce radiologists' workload. The company also offers ChestEye for detecting various chest X-ray findings and ChestEye Quality for real-time quality assurance, as well as CT and musculoskeletal imaging solutions. Sectra's acquisition of Oxipit is seen as a strategic move to expand its autonomous radiology AI capabilities and integrate these advanced tools into its enterprise PACS portfolio.
Overall: PositiveStrengths
- Autonomous AI for clearing normal chest X-rays, significantly reducing radiologist workload.
- High sensitivity (99.9%) in identifying normal chest X-rays with ChestLink.
- CE Class IIb certification for ChestLink, demonstrating rigorous regulatory and clinical validation.
- Comprehensive CXR Suite offering CAD, quality assurance, and autonomous reporting.
- Expansion into CT and musculoskeletal imaging with solutions like CT Eyeu2122.
- Seamless integration into existing radiology workflows.
- Potential for increased capacity and efficiency in radiology departments.
- Strong backing from Sectra's global footprint and established clinical partnerships.
Limitations
- Autonomous AI in medical imaging is a relatively new and evolving field, raising questions about legal ramifications and adoption.
- Sectra (the parent company) has been noted for being expensive and focusing on larger sites for new sales.
- Some concerns about Sectra's shift from a 'family atmosphere' to a more corporate entity with higher staff turnover and less personalized service.
- Sectra's cloud implementation (SectraONE) has reportedly not been smooth for some regions.
- Sectra PACS requires significant bandwidth, which can cause performance issues for remote radiologists.
Based on reviews from: Oxipit, RT Medical Systems, Hardian Health, Sectra Acquires AI Radiology Startup Oxipit to Scale Autonomous Diagnostic Imaging, Sectra acquires Oxipit, advancing autonomous AI capabilities in diagnostic imaging, Sectra completes Oxipit acquisition, accelerating autonomous AI in radiology - PR Newswire, Oxipit enters agreement to be acquired by Sectra to scale autonomous AI in radiology, CXR Suite - Oxipit AI, CT Suite | Oxipit, Sectra Acquires AI Company Oxipit - MarketScreener, First AI Doctor Approved By FDA | Oxipit Explained - YouTube, Sectra acquires Oxipit, advancing autonomous AI capabilities in diagnostic imaging, Leading Oxipit's next chapter, Reddit, G2
Last updated: 2026-10-01
Videos
News, demos, and interviews about Oxipit (part of Sectra group).
Videos load interactively. If none appear, search YouTube for Oxipit (part of Sectra group) →
Press & Coverage
Frequently Asked Questions
Related Companies
BastionGPT (Bastion Intelligence) is a healthcare AI company that provides a HIPAA-compliant AI assistant and medical scribe specifically designed for healthcare professionals. The platform allows clinicians, practices, and health systems to utilize generative AI for various tasks without compromising patient data security. It integrates leading AI models like GPT, Claude, and Gemini, offering a multi-model, […]
Videa (formerly VideaHealth) is a healthcare AI company focused on transforming dentistry through artificial intelligence. The company develops AI software that analyzes dental radiographs (X-rays) to assist dentists in detecting various oral conditions, such as cavities, gum disease, periapical lesions, calculus, and periodontal bone loss. Their core product, the “VideaAI” platform, is an FDA-cleared software […]
The Real Estate Physician is a company that empowers physicians to achieve financial independence through real estate investing. Founded by Dr. Cherry Chen and Alex Luu in 2018, the company provides guidance, education, and support to help healthcare professionals invest in commercial real estate opportunities. They aim to help physicians put their money to work, […]
Surgical Reality is a healthcare AI company that specializes in advanced AI-powered 3D medical imaging and surgical planning software for thoracic surgery. Their core product, the Surgical Reality Viewer, converts standard CT scans into high-fidelity, patient-specific 3D models of the entire lung within minutes. This technology is designed to assist trained healthcare professionals with preoperative […]
SureMediks, a product of Rasimo Systems, LLC, is an AI-powered Clinical Operating System designed for longitudinal care, aiming to transform episodic healthcare into continuous, intelligent, and personalized patient management. The platform integrates patients, healthcare providers, clinical protocols, AI, connected medical devices, and electronic medical records into a unified ecosystem. SureMediks processes continuous real-world patient data […]
SOAP Health is a healthcare AI company focused on improving early disease detection and diagnosis at the point of care. The company’s mission is to save lives by augmenting physicians’ capabilities to perform in-depth risk and symptom assessments. They aim to achieve this by leveraging conversational and generative AI to enhance patient intake, streamline risk […]